insulin glargine-yfgn 100 UNT/ML Injectable Solution

RxCUI: 2563976
RxNorm name: insulin glargine-yfgn 100 UNT/ML Injectable Solution
Display name: insulin glargine-yfgn 100 UNT/ML Injectable Solution
Full name: insulin glargine-yfgn 100 UNT/ML Injectable Solution
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761201	Semglee	insulin glargine-yfgn	351(k) Interchangeable	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Insulin Glargine	INSULIN GLARGINE-YFGN	Biocon Biologics Inc.	3ac85ebb-5594-59c8-77fd-df254329d151	2026-01-23	Warnings, Adverse reactions	Exact identifier rxcui: 2563976
SEMGLEE	INSULIN GLARGINE-YFGN	Biocon Biologics Inc.	8cf5544f-87d6-468b-f6ae-898b1fdb5d80	2025-03-03	Warnings, Adverse reactions	Exact identifier rxcui: 2563976

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
8cf5544f-87d6-468b-f6ae-898b1fdb5d80	insulin glargine-yfgn 100 UNT/ML Injectable Solution [PSN] · insulin glargine-yfgn 100 UNT/ML Injectable Solution [SCD]	2	14	These highlights do not include all the information needed to use SEMGLEE safely and effectively. See full prescribing information for SEMGLEE. SEMGLEE ® (insulin glargine-yfgn) injection, for subcutaneous use Initial U.S. Approval: 2021 SEMGLEE ® (insulin glargine-yfgn) is biosimilar* to LANTUS (insulin glargine).	20250303
3ac85ebb-5594-59c8-77fd-df254329d151	insulin glargine-yfgn 100 UNT/ML Injectable Solution [PSN] · insulin glargine-yfgn 100 UNT/ML Injectable Solution [SCD]	2	8	These highlights do not include all the information needed to use INSULIN GLARGINE-YFGN safely and effectively. See full prescribing information for INSULIN GLARGINE-YFGN. INSULIN GLARGINE-YFGN injection, for subcutaneous use Initial U.S. Approval: 2021 This product is SEMGLEE (insulin glargine-yfgn). SEMGLEE (insulin glargine-yfgn) is biosimilar* to LANTUS (insulin glargine).	20250303